Naserke H E, Durinovic-Bellò I, Seidel D, Ziegler A G
Institute of Diabetes Research and Academic Hospital Schwabing, Koelner Platz 1, D-80804 Munich, Germany.
Immunogenetics. 1996;45(2):87-96. doi: 10.1007/s002510050176.
We recently described the T-cell receptor (TCR) beta chain CDR3 motif S-SDRLG-NQPQH (BV8S1-BJ1S5) in an islet-specific T-cell clone (K2.12) from a type 1 diabetic patient (AS). A similar motif (RLGNQ) was also reported in a T-cell clone of non-obese diabetic (NOD) mice by others. In order to determine the frequency of our motif in selected and unselected T-cell populations, we cloned and sequenced the CDR3 region of BV8S1-BJ1S5 transcripts. These transcripts were derived from unstimulated peripheral blood T lymphocytes from two type 1 diabetic patients (AS and FS) and their non-diabetic sibling (WS), as well as from an islet-specific T-cell line of one of the patients. In addition, we compared the structure and composition of the CDR3 region in BV8S1-BJ1S5 transcripts from peripheral blood T cells between the patients and their non-diabetic sibling (>50 sequences each). We found that 30% of the islet-specific T-cell line cDNA clones expressed the entire sequence-motif, whereas it was absent in the clones of unstimulated peripheral blood T cells from both patients and their non-diabetic sibling. The average length of the CDR3 region was shorter in the patients (mean AS 9.9, FS 9.9, versus WS 10.7, p = 0.0037) and the number of inserted nucleotides in N nucleotide addition at the DJ-junction lower (mean AS 3.5, FS 3. 2, versus WS 5.2, P = <10(-4)) as compared with their non-diabetic sibling. Moreover, the pattern of amino acid usage in the CDR3 region was dissimilar at positions 5 and 6, where polar amino acids predominated in both diabetic siblings. In contrast, basic amino acids are preferentially used at position 5 in the clones of the non-diabetic sibling. These data provide information on the general structure of the TCR(BV8S1-BJ1S5) CDR3 region in type 1 diabetes and may indicate differences in the amino and nucleic acid composition of the TCR beta chain CDR3 region between two type 1 diabetic patients and their non-diabetic sibling.
我们最近在一名1型糖尿病患者(AS)的胰岛特异性T细胞克隆(K2.12)中描述了T细胞受体(TCR)β链互补决定区3(CDR3)基序S-SDRLG-NQPQH(BV8S1-BJ1S5)。其他人在非肥胖糖尿病(NOD)小鼠的一个T细胞克隆中也报道了类似的基序(RLGNQ)。为了确定我们的基序在选定和未选定的T细胞群体中的频率,我们克隆并测序了BV8S1-BJ1S5转录本的CDR3区域。这些转录本来自两名1型糖尿病患者(AS和FS)及其非糖尿病同胞(WS)未受刺激的外周血T淋巴细胞,以及其中一名患者的胰岛特异性T细胞系。此外,我们比较了患者及其非糖尿病同胞外周血T细胞中BV8S1-BJ1S5转录本CDR3区域的结构和组成(每人>50个序列)。我们发现,30%的胰岛特异性T细胞系cDNA克隆表达了完整的序列基序,而在患者及其非糖尿病同胞未受刺激的外周血T细胞克隆中则不存在。与他们的非糖尿病同胞相比,患者CDR3区域的平均长度较短(AS平均为9.9,FS为9.9,而WS为10.7,p = 0.0037),并且在DJ连接点处N核苷酸添加中插入核苷酸的数量较少(AS平均为3.5,FS为3.2,而WS为5.2,P = <10(-4))。此外,CDR3区域氨基酸使用模式在第5和第6位不同,在两名糖尿病同胞中极性氨基酸占主导。相比之下,在非糖尿病同胞的克隆中,第5位优先使用碱性氨基酸。这些数据提供了1型糖尿病中TCR(BV8S1-BJ1S5)CDR3区域的总体结构信息,并可能表明两名1型糖尿病患者及其非糖尿病同胞之间TCRβ链CDR3区域的氨基酸和核酸组成存在差异。